Geographic variation in the prevalence of kaposi sarcoma-associated herpesvirus and risk factors for transmission

Journal of Infectious Diseases

Volumn 199, Issue 10, 2009, Pages 1449-1456

  Sanjose, Silvia De ^a,b,m   Mbisa, Georgina ^l   Perez Alvarez, Susana ^a   Benavente, Yolanda ^a,b   Sukvirach, Sukhon ^c   Hieu, Nguyen Trong ^d   Shin, Hai Rim ^e,k   Anh, Pham Thi Hoang ^d   Thomas, Jaiyeola ^f   Lazcano, Eduardo ^g   Matos, Elena ^h   Herrero, Rolando ⁱ   Muñoz, Nubia ^j   Molano, Monica ^j   Franceschi, Silvia ^e   Whitby, Denise ^l  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c NATIONAL CANCER INSTITUTE   (Thailand)

^d Hung Vuong Hospital   (Viet Nam)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f UNIVERSITY OF IBADAN   (Nigeria)

^g INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^h UNIVERSIDAD DE BUENOS AIRES   (Argentina)

ⁱ Proyecto Epidemiologico Guanacaste   (Costa Rica)

^j Instituto Nacional de Cancerología   (Colombia)

^k National Cancer Center   (South Korea)

^l SAIC FREDERICK INC   (United States)

^m BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; ARGENTINA; ARTICLE; COLOMBIA; COSTA RICA; EDUCATIONAL STATUS; FEMALE; GEOGRAPHIC DISTRIBUTION; HERPES VIRUS INFECTION; HETEROSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; INFECTION RISK; KOREA; MAJOR CLINICAL STUDY; NIGERIA; ORAL CONTRACEPTION; PREVALENCE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SMOKING; SPAIN; THAILAND; VIET NAM; VIRUS TRANSMISSION; WART VIRUS;

ADULT; ANTIGENS, VIRAL; COLOMBIA; CROSS-CULTURAL COMPARISON; FEMALE; GLYCOPROTEINS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; MIDDLE AGED; NIGERIA; ODDS RATIO; PREVALENCE; RISK FACTORS; SARCOMA, KAPOSI; SEXUAL BEHAVIOR; THAILAND; VIRAL PROTEINS;

EID: 65549112277     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/598523     Document Type: Article

References (32)

1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332:1186-91.
2. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
3. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86:1276-80.
4. Ablashi D, Chatlynne L, Cooper H, et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 1999; 81:893-7.
5. Andreoni M, El Sawaf G, Rezza G, et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst 1999; 91:465-9.
6. Sitas F, Newton R, Boshoff C. Increasing probability of mother-to-child transmission of HHV-8 with increasing maternal antibody titer for HHV-8. N Engl J Med 1999; 340:1923-.
7. de Sanjosé S, Marshall V, Solà J, et al. Prevalence of Kaposi's sarcomaassociated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer 2002; 98:155-8.
8. Gambús G, Bourboulia D, Esteve A, et al. Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS 2001; 15:1167-74.
9. Valdarchi C, Serraino D, Cordiali Fei P, et al. Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy. Infection 2007; 35:22-5.
10. Whitby D, Smith NA, Matthews S, et al. Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis 1999; 179:234-6.
11. Zavitsanou A, Sypsa V, Petrodaskalaki M, Kalapothaki V, Whitby D, Hatzakis A. Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: seroprevalence and associated factors. J Med Virol 2007; 79:591-6.
12. Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis 2000; 181:1562-8.
13. Sosa C, Benetucci J,HannaC, et al.Humanherpesvirus 8 can be transmitted through blood in drug addicts. Medicina (B Aires) 2001; 61:291-4.
14. Engels EA, Atkinson JO, Graubard BI, et al. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007; 196:199-207.
15. Pellett PE, Wright DJ, Engels EA, et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003; 43:1260-8.
16. Weiss RA, Whitby D, Talbot S, Kellam P, Boshoff C. Human herpesvirus type 8 and Kaposi's sarcoma. J Natl Cancer Inst Monogr 1998; 51-4.
17. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338:948-54.
18. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-8.
19. Malope BI, MacPhail P, Mbisa G, et al. No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS 2008; 22:519-26.
20. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366:991-8.
21. Herrero R, Schiffman MH, Bratti C, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1997; 1:362-75.
22. Vaccarella S, Franceschi S, Herrero R, et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 2006; 15:326-33.
23. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol IX. Publication 160. Lyon, France: International Agency for Research on Cancer Scientific Publications, 2007.
24. Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 2003; 187:1780-5.
25. Mbulaiteye SM, Biggar RJ, Pfeiffer RM, et al. Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr 2005; 38:474-9.
26. Cattani P, Capuano M, Cerimele F, et al. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virusseronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol 1999; 37:1150-3.
27. de Souza VA, Sumita LM, Nascimento MC, et al. Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J Infect Dis 2007; 196:844-52.
28. Dedicoat M, Newton R, Alkharsah KR, et al. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 2004; 190: 1068-75.
29. Enbom M, Urassa W, Massambu C, Thorstensson R, Mhalu F, Linde A. Detection of human herpesvirus 8 DNA in serum from blood donors with HHV-8 antibodies indicates possible bloodborne virus transmission. J Med Virol 2002; 68:264-7.
30. Sriplung H, Parkin DM. Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand. Cancer 2004; 101: 2660-6.
31. Mbulaiteye SM, Atkinson JO, Whitby D, et al. Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study. J Clin Virol 2006; 35:442-9.
32. Goedert JJ, Vitale F, Lauria C, et al. Risk factors for classical Kaposi's sarcoma. J Natl Cancer Inst 2002; 94:1712-8.